Awarded
Terms and Conditions for the Supply of Centrally Procured Vaccines - SARS-CoV-2 VACCINE SUPPLY AGREEMENT
£1
The Department for Business, Energy and Industrial Strategy (BEIS)Pfizer Limited
goods
Contract Details
- Tender Value
- £1
- Stage
- Awarded
- Published
- Awarded
Timeline
Awarded
Start
Disclosed
End
Description
Procurement of the Covid-19 NVX-CoV2373 Vaccine.
Related Contracts
From This Buyer
- Development of a Publicly Available Specification (PAS) for Energy Savings Opportunity Scheme (ESOS) net zero audits
£247,000 ·
- Domestic Private Rented Sector Evaluation - Landlord Panel Survey
£24,630 ·
- Flexibility Innovation Programme: Laboratory testing and demonstration of interoperable DSR applications in settings indicative of the real world.
- Heat Pump Ready Programme - Stream 3: Trial Support and Learning
From This Supplier
- Additional PF-07321332 Supply Agreement for Pandemic Purposes
£1 ·
- TERMS AND CONDITIONS FOR THE SUPPLY OF CENTRALLY PROCURED VACCINES
£1 ·
- PF-07321332 Supply Agreement for Pandemic Purposes
£1 ·
- Terms and Conditions for the Supply of Centrally Procured Vaccines - SARS-CoV-2 VACCINE SUPPLY AGREEMENT
£1 ·
In This Category
- Twilio SMS Authentication
£99,999 ·
- Award of Conductive Energy Devices and Associated Equipment
£1,764,041 ·
- WSFT - Capital Purchase - IT - Dell laptops
£500,000 ·
- Provision of Office Supplies
£32,000,000 ·
Ref: 846275db-46ef-47b3-8300-979c00896f82-393853 · Sourced from Contracts Finder
View source notice